Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet
Open Access
- 1 February 1998
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 39 (2) , 457-462
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.Journal of Clinical Investigation, 1997
- Molecular Basis of Fish-Eye Disease in a Patient From SpainArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- 132 Protective effect of human apo A-II overexpression on atherogenesis in transgenic miceAtherosclerosis, 1997
- Cholesterol Efflux, Lecithin−Cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein A-I and Apolipoprotein A-I/Apolipoprotein A-II Transgenic Mice Consistent with the Latter Being Less Effective for Reverse Cholesterol TransportBiochemistry, 1997
- Functional Lecithin:Cholesterol Acyltransferase Deficiency and High Density Lipoprotein Deficiency in Transgenic Mice Overexpressing Human Apolipoprotein A-IIJournal of Biological Chemistry, 1996
- Contrasting in Vivo Effects of Murine and Human Apolipoprotein A-IIJournal of Biological Chemistry, 1996
- Apolipoprotein A-II Production Rate Is a Major Factor Regulating the Distribution of Apolipoprotein A-I Among HDL Subclasses LpA-I and LpA-I:A-II in Normolipidemic HumansArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The properties of HDL in genetically engineered miceCurrent Opinion in Lipidology, 1994
- Protein composition determines the anti-atherogenic properties of HDL in transgenic miceNature, 1993
- Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986